BERIL-1: Biomarker results from targeted sequencing of circulating tumor DNA (ctDNA) and archival tissue in a randomized phase II study of buparlisib (BKM120) or placebo plus paclitaxel in patients ...

Researchers at Penn’s Abramson Cancer Center and Perelman School of Medicine recently discovered how to find and treat dormant cancer cells to help identify — and prevent recurrence in breast cancer ...